ITI Pharma and Healthcare Fund holds 38 instruments (99.31% equity), led by Sun Pharmaceutical Industries Limited (11.96%), Divi's Laboratories Limited (9.51%) and Apollo Hospitals Enterprise Limited (5.45%), as of its 30 September 2026 SEBI-mandated monthly disclosure.
This page shows the complete disclosed portfolio of ITI Pharma and Healthcare Fund, managed by ITI Mutual Fund, based on its monthly portfolio disclosure dated 30 September 2026. The fund holds 38 instruments with an equity allocation of 99.31%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.
ITI Pharma and Healthcare Fund's top 10 holdings account for 56.97% of its portfolio, more concentrated than the Thematic category average of 49.2%. Healthcare is its largest sector exposure at 97.17% of net assets, spread across 3 sectors in total. Since its 31 August 2026 disclosure, the fund added 1 new position and exited 1 position, with Sun Pharmaceutical Industries Limited seeing the largest move (-0.62pp to 11.96%).
Equity holdings grouped by sector, % to NAV. "Other" covers debt, cash and other non-equity instruments, plus any equity holding without a classified sector.
Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.
| Stock | Weight | Change |
|---|---|---|
| Mankind Pharma Limited | 3.31% → 3.78% | ▲ +0.47 |
| Dr. Reddy's Laboratories Limited | 4.31% → 4.78% | ▲ +0.47 |
| Sai Life Sciences Limited | 1.59% → 1.87% | ▲ +0.28 |
| Divi's Laboratories Limited | 9.23% → 9.51% | ▲ +0.28 |
| Supriya Lifescience Limited | 0.81% → 1% | ▲ +0.19 |
| Abbott India Limited | 1.97% → 2.14% | ▲ +0.17 |
| Alkem Laboratories Limited | 2.92% → 3.09% | ▲ +0.17 |
| Aster DM Healthcare Limited | 1.47% → 1.59% | ▲ +0.12 |
| Stock | Weight | Change |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 12.58% → 11.96% | ▼ -0.62 |
| Lupin Limited | 2.43% → 2.04% | ▼ -0.39 |
| Max Healthcare Institute Limited | 4.84% → 4.49% | ▼ -0.35 |
| Apollo Hospitals Enterprise Limited | 5.72% → 5.45% | ▼ -0.27 |
| Global Health Limited | 2.98% → 2.85% | ▼ -0.13 |
| Neuland Laboratories Limited | 3.18% → 3.07% | ▼ -0.11 |
% to NAV of the fund's current top holdings over its last 2 monthly disclosures (Aug – Sept 2026).
New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.
Source: ITI Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 30 September 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.